Ipamorelin — 10 mg

Selective Growth Hormone Secretagogue & Ghrelin Receptor Agonist

Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue studied for its ability to activate the ghrelin/growth hormone secretagogue receptor (GHS-R1a). This interaction stimulates signaling within the hypothalamic-pituitary axis and promotes the release of endogenous growth hormone.

A key area of interest surrounding Ipamorelin is its relatively selective effect on growth hormone secretion. Research has examined its ability to produce growth-hormone release while having less influence on certain other pituitary hormones compared with some earlier growth hormone-releasing compounds.

Because growth hormone participates in numerous physiological processes, Ipamorelin has become a subject of research involving growth-hormone signaling, IGF-1 pathways, body composition, protein metabolism, tissue repair and recovery, and metabolic function.

Key Areas of Research

• Growth hormone secretagogue activity
• GHS-R1a (ghrelin receptor) activation
• Endogenous growth hormone release
• Growth hormone and IGF-1 signaling pathways
• Body-composition and metabolic research
• Protein synthesis and tissue-repair pathways
• Recovery and regenerative signaling
• Pulsatile growth-hormone physiology

Product Strength: 10 mg

FOR RESEARCH USE ONLY